Pharmacodynamics of Injection of Cisatracurium Base on Lean Body Mass Pattern to Maintain Deep Neuromuscular Blockade in Obese Patients

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 16, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

July 3, 2022

Conditions
Obese PatientsLaparoscopic Colorectal Surgery
Interventions
BEHAVIORAL

base on Lean Body Mass Pattern

PTC(post-tetanic count) was measured every 6min during the operation, and single injection of 0.05 (1ED95) mg/kg cisatracurium that was calculated based on lean body weight mass pattern once when PTC \> 2.

BEHAVIORAL

base on Actual Body Weight

PTC was measured every 6min during the operation, and single injection of 0.05 (1ED95) mg/kg cisatracurium that was calculated based on actual body weight once when PTC \> 2.

GENETIC

obese patients

obese patients with elective laparoscopic colorectal surgery were selected,and the inclusion criteria were as follows: age 18-65, body mass index (BMI) 30-35, waist circumference (WC) : female ≥80cm, male ≥90cm, and American Society of Anesthesiologists (ASA) grade Ⅰ \~ Ⅲ.

GENETIC

normal patients

normal patients with elective laparoscopic colorectal surgery whose body mass index (BMI) 18-24 were selected,and American Society of Anesthesiologists (ASA) grade Ⅰ \~ Ⅲ.

Trial Locations (1)

Unknown

The First hosptial of Qinhuangdao, Qinhuangdao

All Listed Sponsors
lead

The First Hospital of Qinhuangdao

OTHER_GOV

NCT05391958 - Pharmacodynamics of Injection of Cisatracurium Base on Lean Body Mass Pattern to Maintain Deep Neuromuscular Blockade in Obese Patients | Biotech Hunter | Biotech Hunter